Searched for
MANEESH PHARMA
Koye Pharma next on Warburg's health playGlobal private equity fund Warburg Pincus is nearing a deal to buy Koye Pharma. The Mumbai-based drugmaker focuses on women's health, respi...- US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore dealUS private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is ...
- Think beyond gold, silver is shining well for investors: Will it reach Rs 3 lakh in 5 years?Silver prices have risen by 54% in just 1 year. In the last 5 years, the white metal has given 19.10% annualised return. The gold-silver ra...
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
- Sekhmet, Nirma in fray for Glenmark's API businessSekhmet Pharmaventures and Nirma Group are in competition to acquire Glenmark Life Sciences (GLS), the 82.85% subsidiary of Glenmark Pharma...
- Flat US business hits pharma stock returnsThe domestic pharma sector may have been drawing top dollar deals and driving M&As based on opportunities of growth, but stock markets seem...
- Nifty, Sensex post weekly losses as investors’ risk appetite shrinksDuring the four-day sell-off in the market, investors’ notional wealth has declined by Rs 10.3 lakh crore.
- Ditch FOMO, this is not the time for taking active calls: Maneesh Dangi"Small caps and midcaps would underperform mega caps over six, eight months and markets would struggle," says the macro investor and adviso...
- Should you use the market correction to buy value stocks?It is a macro led bull market correction. Time to look at value stocks now
- Back at work, employees experience a brand ‘new’ workplaceFrom numbering chairs to prevent accidental exchanges, converting corridors and walkways to ‘one-ways’ and encouraging use of alternate sta...
- 10 people who made it big in fields they didn't have a degree inIt takes immense courage to leave what one has and strive for what one really wants, and make it big in that field.
- What should you do in case of a mutual fund merger?You can remain invested or exit the fund depending on the reason for the merger. Find out how you should act if the union has been triggere...
- Things to consider before investing in sectoral mutual fundsThough some sectoral funds have given better returns than the equity diversified funds in the past few years, don't invest blindly in them.
- MRTPC to probe drug cos' 'refusal' to sell to Big RetailCorporate retail chains such as Subhiksha and Reliance Retail that have faced problems sourcing medicines from drug wholesalers in the past...
- Vinay Sapte takes Maneesh Pharma to a new highFrom targeting the global relief pharma market to making 11 acquisitions in two years, Sapte's instincts never failed him.
- Maneesh Pharma buys 51% stake in US firm SynovicsManeesh has become the fourth Indian pharma firm after Sun Pharmaceuticals, Wockhardt and Glenmark, to acquire control of an American drug ...
- Kopran on the blockThe Mumbai-based Kopran is on the block. The promoters and Clearwater Capital Partners of Cyprus, who together hold 44% equity, are believe...
- Cos slash prices of popular medicinesPopular medications to treat chest pain, anxiety, allergy and diabetes have become cheaper by between 2% and 39%.
- Unichem plans Rs 110-cr pharma buyout in BrazilMid-sized drug maker Unichem Laboratories is set to acquire a pharma company in Brazil, the fastest growing pharmaceutical market in the wo...
Load More
